Chargement en cours...
Efficacy of tiotropium–olodaterol fixed-dose combination in COPD
Tiotropium–olodaterol, formulated in the Respimat soft-mist inhaler, is an inhaled fixed-dose combination (FDC) of a long-acting muscarinic antagonist (LAMA) and a long-acting β(2)-agonist (LABA), commercialized under the name of Spiolto or Stiolto. The efficacy of tiotropium–olodaterol 5–5 μg once...
Enregistré dans:
| Publié dans: | Int J Chron Obstruct Pulmon Dis |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove Medical Press
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5167492/ https://ncbi.nlm.nih.gov/pubmed/28008243 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S92840 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|